- Eli Lilly (NYSE:LLY) is in talks with the Trump administration to provide discounted drugs to consumers as part of the new TrumpRx direct-to-consumer website.
- CNBC broke the news, citing a White House official.
- A request for comment from Eli Lilly has yet to be returned to Seeking Alpha.
- The development comes after President Trump earlier Tuesday announced the launch of TrumpRx, starting with Pfizer (PFE) offering four of its medications at a discounted price.
Eli Lilly in discussions with White House for TrumpRx deal – report
